Log in to save to my catalogue
Log in to save to my catalogue

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists...

| Ask | Become a Library member

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b45064e466d4e25abc84ea3e931b788

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

About this item

Full title

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Author / Creator

Htoo, Phyo T , Tesfaye, Helen , Schneeweiss, Sebastian , Wexler, Deborah J , Everett, Brendan M , Glynn, Robert J , Schmedt, Niklas , Koeneman, Lisette , Déruaz-Luyet, Anouk , Paik, Julie M and Patorno, Elisabetta

Publisher

England: BioMed Central Ltd

Journal title

Cardiovascular Diabetology, 2024-03, Vol.23 (1), p.103-2, Article 103

Language

English

Formats

Articles

Publication information

Publisher

England: BioMed Central Ltd

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1b45064e466d4e25abc84ea3e931b788

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1b45064e466d4e25abc84ea3e931b788

Other Identifiers

ISSN

1475-2840

E-ISSN

1475-2840

DOI

10.1186/s12933-024-02190-6

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections